Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP

Publication date: Available online 26 March 2021Source: European UrologyAuthor(s): Andrew G. Robinson, Jason P. Izard, Francisco E. Vera-Badillo
Source: European Urology - Category: Urology & Nephrology Source Type: research